Abstract
Objectives
Accumulating evidence from cross-sectional studies suggests that the serum creatinine-to-cystatin C ratio (CCR) may be a useful biomarker for sarcopenia. This study aimed to assess the cross-sectional and longitudinal associations of CCR with sarcopenia and its parameters in community-dwelling older adults.
Design
Cross-sectional and longitudinal study.
Setting and Participants
This 6-year prospective cohort study included the repeated measurement data from 1,253 Japanese residents (662 males and 591 females) aged ≥65 years who underwent medical checkups in Kusatsu and Hatoyama, Japan. A total of 4,421 observations were collected.
Measurements
The CCR was grouped into quartiles by sex (Q1–Q4) using Q4 as the reference category. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 algorithm. Skeletal muscle mass index (SMI) measured using segmental multifrequency bioelectrical impedance analysis, handgrip strength (HGS), usual gait speed (UGS), and maximal gait speed (MGS) were measured repeatedly as sarcopenia parameters. The association of the CCR with changes in sarcopenia, SMI, HGS, UGS, and MGS during the 6-year period were analyzed using a generalized linear mixed-effects model.
Results
The prevalence of sarcopenia at baseline was 13.1% (11.9% in males and 14.5% in females). In a cross-sectional analysis, the CCR quartile was inversely associated with sarcopenia and was positively associated with SMI, HGS, and MGS (P for trend < 0.001). In a longitudinal analysis during the 6 years, a significant increase in sarcopenia in Q2 (B = 1.1% point/year; P = 0.026 for group-by-time interaction) and significant declines in SMI (B = −0.01 kg/m2/year; P = 0.044 for group-by-time interaction) and MGS (B = −0.008 m/sec/year; P = 0.041 for group-by-time interaction) in Q1 were observed compared with Q4. However, the dose-response relationship was significant only for MGS (P = 0.033 for trend). No significant group-by-time interaction was observed for HGS. CCR was not significantly associated with UGS either cross-sectionally or longitudinally.
Conclusions
CCR is a useful biomarker regarding the status of sarcopenia. It may be used for sarcopenia screening even in older adults whose physical function is difficult to assess. However, further longitudinal studies are needed to determine whether CCR can be a predictor of future sarcopenia.
Similar content being viewed by others
References
Morley, J.E. Hormones and sarcopenia. Curr Pharm Des. 2017;23:4484–4492. doi:https://doi.org/10.2174/1381612823666161123150032
Dos Santos, L., Cyrino, E.S., Antunes, M., Santos, D.A., and Sardinha, L. B. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J Cachexia Sarcopenia Muscle. 2017;8:245–250. doi:https://doi.org/10.1002/jcsm.12160
Sim, M., Prince, R.L., Scott, D., Daly, R.M., Duque, G., Inderjeeth, C.A., et al. Sarcopenia definitions and their associations with mortality in older Australian women. J Am Med Dir Assoc. 2019;20:76–82.e2. doi:https://doi.org/10.1016/j.jamda.2018.10.016
Lin, T., Dai, M., Xu, P., Sun, L., Shu, X., Xia, X., et al. Prevalence of sarcopenia in pain patients and correlation between the two conditions: a systematic review and meta-analysis. J Am Med Dir Assoc. 2022;23:902.e1–902.e20. doi:https://doi.org/10.1016/j.jamda.2022.02.005.
Kusunoki, H., Tsuji, S., Wada, Y., Fukai, M., Nagai, K., Itoh, M., et al. Relationship between sarcopenia and the serum creatinine/cystatin C ratio in Japanese rural community-dwelling older adults. JCSM Clinical Reports, 2018;3:1–14. doi:https://doi.org/10.17987/jcsm-cr.v3i1.57
Osaka, T., Hamaguchi, M., Hashimoto, Y., Ushigome, E., Tanaka, M., Yamazaki, M., et al. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. Diabetes Res Clin Pract. 2018;139:52–58. doi:https://doi.org/10.1016/j.diabres.2018.02.025
Sim, M., Dalla Via, J., Scott, D., Lim, W.H., Hodgson, J.M., Zhu, K., et al. Creatinine to cystatin c ratio, a biomarker of sarcopenia measures and falls risk in community-dwelling older women. J Gerontol A Biol Sci Med Sci. 2021;77:1389–1397. doi:https://doi.org/10.1093/gerona/glab369
Taniguchi, Y., Fujiwara, Y., Murayama, H., Yokota, I., Matsuo, E., Seino, S., et al. Prospective study of trajectories of physical performance and mortality among community-dwelling older Japanese. J Gerontol A Biol Sci Med Sci. 2016;71:1492–1499. doi:https://doi.org/10.1093/gerona/glw029
Murayama, H., Nishi, M., Shimizu, Y., Kim, M.J., Yoshida, H., Amano, H., et al. The Hatoyama Cohort Study: design and profile of participants at baseline. J Epidemiol. 2012;22:551–558. doi:https://doi.org/10.2188/jea.JE20120015
Kim, M., Shinkai, S., Murayama, H., Mori, S. Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population body composition in older adults. Geriatr Gerontol Int. 2015;15:1013–1022. doi:https://doi.org/10.1111/ggi.12384
Baumgartner, R.N., Koehler, K.M., Gallagher, D., Romero, L., Heymsfield, S.B., Ross, R.R., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–763. doi:https://doi.org/10.1093/oxfordjournals.aje.a009520
Seino, S., Shinkai, S., Fujiwara, Y., Obuchi, S., Yoshida, H., Hirano, H., et al. Reference values and age and sex differences in physical performance measures for community-dwelling older Japanese: a pooled analysis of six cohort studies. PloS One. 2014;9,e99487. doi:https://doi.org/10.1371/journal.pone.0099487
Shinkai, S., Watanabe, S., Kumagai, S., Fujiwara, Y., Amano, H., Yoshida, H., et al. Walking speed as a good predictor for the onset of functional dependence in a Japanese rural community population. Age Ageing. 2000; 29(5):441–446.
Wang, C.Y., Lin, Y.H., Chen, T.R., Liu, M.H., Chen, Y.C. Gait Speed Measure:The Effect of Different Measuring Distances and the Inclusion and Exclusion of Acceleration and Deceleration. Percept Mot Skills. 2012;114(2), 469–478. https://doi.org/10.2466/10.25.26.PMS.114.2.469-478)
Chen, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Chou, M. Y., Iijima, K., et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:https://doi.org/10.1016/j.jamda.2019.12.012
Kitamura, A., Seino, S., Abe, T., Nofuji, Y., Yokoyama, Y., Amano, H., et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021;12:30–38. doi:https://doi.org/10.1002/jcsm.12651
Burke, W.J., Roccaforte, W.H., Wengel, S.P. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4:173–178. doi:https://doi.org/10.1177/089198879100400310
Folstein, M.F., Folstein, S.E., McHugh, P.R. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198. doi:https://doi.org/10.1016/0022-3956(75)90026-6
Yanishi, M., Kinoshita, H., Tsukaguchi, H., Kimura, Y., Koito, Y., Sugi, M., et al. The creatinine/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients. Int Urol Nephrol. 2019;51:79–83. doi:https://doi.org/10.1007/s11255-018-2015-6
Kashani, K.B., Frazee, E.N., Kukrálová, L., Sarvottam, K., Herasevich, V., Young, P.M., et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med. 2017;45:e23–e29. doi:https://doi.org/10.1097/ccm.0000000000002013
Tabara, Y., Kohara, K., Okada, Y., Ohyagi, Y., Igase, M. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study. Clin Nutr. 2020;39:1857–1862. doi:https://doi.org/10.1016/j.clnu.2019.07.027
Tan, L., Li, R., Hu, X., Zhu, Y., Bao, T., Zuo, Y., et al. (2020). Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults. Sci Rep. 2020;10:14028. doi:https://doi.org/10.1038/s41598-020-71028-4
Fiser, W.M., Hays, N.P., Rogers, S.C., Kajkenova, O., Williams, A.E., Evans, C. M., et al. Energetics of walking in elderly people: factors related to gait speed. J Gerontol A Biol Sci Med Sci. 2010;65A:1332–1337. doi:https://doi.org/10.1093/Gerona/glq137
Studenski, S., Perera, S., Patel, K., Rosano, C., Faulkner, K., Inzitari, M., et al. Gait speed and survival in older adults. JAMA. 2011;305:50–58. doi:https://doi.org/10.1001/jama.2010.1923
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14:877–882. doi:https://doi.org/10.1016/j.jamda.2013.05.009
Lim, J.P., Leung, B.P., Ding, Y.Y., Tay, L., Ismail, N.H., Yeo, A., et al. Monocytechemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity. Clin Interv Aging. 2015;10:605–609. doi:https://doi.org/10.2147/CIA.S78901
Kos, J., Stabuc, B., Cimerman, N., Brünner, N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem. 1998;44:2556–2557. doi:https://doi.org/10.1093/clinchem/44.12.2556
Colle, A., Tavera, C., Prevot, D., Leung-Tack, J., Thomas, Y., Manuel, Y., et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J Immunoassay. 1992;13:47–60. doi: https://doi.org/10.1080/15321819208019824
Acknowledgments
We would like to thank the residents and staff of the towns of Kusatsu and Hatoyama and our collaborators.
Funding
Funding: This study was supported by grants from the Tokyo Metropolitan Institute of Gerontology; Research Institute of Science and Technology for Society, Japan Science and Technology Agency; Japan Society for the Promotion of Science KAKENHI JP24390173 and JP26310111; the Japan Arteriosclerosis Prevention Fund for the Japan Arteriosclerosis Longitudinal Study (2001–2012); and the towns of Kusatsu and Hatoyama.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical statements: The study protocol was developed in accordance with the guidelines proposed in the Declaration of Helsinki and approved by the Ethics Committee of the Tokyo Metropolitan Institute of Gerontology. All participants provided written informed consent prior to inclusion in the study.
Conflict of interest: The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kitago, M., Seino, S., Shinkai, S. et al. Cross-Sectional and Longitudinal Associations of Creatinine-to-Cystatin C Ratio with Sarcopenia Parameters in Older Adults. J Nutr Health Aging 27, 946–952 (2023). https://doi.org/10.1007/s12603-023-2029-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-023-2029-3